| Financial Year |
March 31 2023 |
| Monetary Funds |
720,767,165.99 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,289,208,857.46 |
| Advances to Suppliers |
35,464,327.97 |
| Other Receivables |
73,459,430.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,634,293,490.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,102,506.61 |
| Total Current Assets |
4,259,434,609.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,211,076.36 |
| Investment Properties |
20,936,668.63 |
| Fixed Assetes |
207,229,114.08 |
| Under-construction Projects |
4,470,276.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,055,163.48 |
| R&D expenses |
-- |
| Goodwill |
299,326,206.44 |
| Long-Term Deferred and Prepaid Expenses |
5,394,637.56 |
| Deferred Income Tax Assets |
61,698,861.74 |
| Other Non-Current Assets |
11,150,723.98 |
| Sub-Total of Non-Current Assets |
989,093,200.42 |
| Total Assets |
5,248,527,809.68 |
| Short-Term Loans |
776,199,846.59 |
| Trading Financial liabilities |
2,133,810.00 |
| Notes Payable |
141,850,000.00 |
| Accounts Payable |
491,431,069.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,761,401.04 |
| Taxes Payable |
41,556,680.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,020,047.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,585,064.21 |
| Other Current Liabilities |
8,769,035.26 |
| Sub-Total of Current Liabilities |
1,592,295,488.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
750,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
73,341,356.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
92,701,814.71 |
| Total Liabilities |
1,684,997,303.68 |
| Paid-In Capital(Or Share Stock) |
1,154,011,922.00 |
| Capital Surplus |
2,415,866,993.44 |
| Surplus Reserve |
18,439,443.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-256,622,676.27 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,563,530,506.00 |
| Owner's Equity（Stockholder's Equity） |
3,563,530,506.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,248,527,809.68 |
